Vaccine created by University of Tartu researchers to prevent a dangerous tropical disease received approval

Last week, the US Food and Drug Administration (FDA) approved the world's first vaccine against the chikungunya virus – Ixchiq. The vaccine candidate has been designed and manufactured at the University of Tartu. The human clinical trials were conducted by the biotechnology company Valneva Austria GmbH.



The University of Tartu Institute of Technology (TÜTI) is a research and development institution established in 2001, which is part of the field of natural and exact sciences. The Institute of Technology provides high-quality education at all levels. Our goal is to lay the foundation for innovative technological solutions and, in doing so, to be a driver of innovation.







Tüti lumega


arvutitehnika eriala podcast

Arvutitehnika ja robootika taskuhääling

Koostöö ettevõtetega